Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
(1) Background: Autoimmune diseases are characterized by autoantibodies directed to a large number of antigenic targets and are measured using serum as sample matrix. Although serum is a very common specimen type, it comes with certain drawbacks. Most importantly, it depends on venous puncture and r...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-08-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/12/8/2026 |
| _version_ | 1797445983327485952 |
|---|---|
| author | Savino Sciascia Chelsea Bentow Massimo Radin Alice Barinotti Irene Cecchi Silvia Foddai Dario Roccatello Michael Mahler |
| author_facet | Savino Sciascia Chelsea Bentow Massimo Radin Alice Barinotti Irene Cecchi Silvia Foddai Dario Roccatello Michael Mahler |
| author_sort | Savino Sciascia |
| collection | DOAJ |
| description | (1) Background: Autoimmune diseases are characterized by autoantibodies directed to a large number of antigenic targets and are measured using serum as sample matrix. Although serum is a very common specimen type, it comes with certain drawbacks. Most importantly, it depends on venous puncture and requires medical personnel for sampling. This is of particular importance in light of the limited healthcare access of patients with autoimmune diseases during the COVID-19 pandemic. Consequently, alternative sample matrices are being explored for the measurement of autoantibodies. Our study aimed to establish the feasibility of measuring autoantibodies in saliva samples using a novel and highly sensitive method for the detection of autoantibodies. (2) Methods: A total of 48 serum/saliva pairs were collected and tested using a novel particle-based multi-analyte technology (PMAT) system for the presence of a wide range of autoantibodies. (3) Results: A high level of correlation was observed between the results obtained with serum and saliva (Spearman’s rho = 0.725). Study participants clearly preferred saliva over serum sampling as part of the usability assessment. (4) Conclusions: Saliva represents a promising alternative sample matrix for the detection of autoantibodies. The usability study showed a clear preference of saliva over serum as a sample matrix. |
| first_indexed | 2024-03-09T13:33:55Z |
| format | Article |
| id | doaj.art-f34c8a33c2bd4bd8988a3db474739874 |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-09T13:33:55Z |
| publishDate | 2022-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-f34c8a33c2bd4bd8988a3db4747398742023-11-30T21:14:47ZengMDPI AGDiagnostics2075-44182022-08-01128202610.3390/diagnostics12082026Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune PatientsSavino Sciascia0Chelsea Bentow1Massimo Radin2Alice Barinotti3Irene Cecchi4Silvia Foddai5Dario Roccatello6Michael Mahler7University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyWerfen Autoimmunity, San Diego, CA 92131, USAUniversity Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyUniversity Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyUniversity Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyUniversity Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyUniversity Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, ItalyWerfen Autoimmunity, San Diego, CA 92131, USA(1) Background: Autoimmune diseases are characterized by autoantibodies directed to a large number of antigenic targets and are measured using serum as sample matrix. Although serum is a very common specimen type, it comes with certain drawbacks. Most importantly, it depends on venous puncture and requires medical personnel for sampling. This is of particular importance in light of the limited healthcare access of patients with autoimmune diseases during the COVID-19 pandemic. Consequently, alternative sample matrices are being explored for the measurement of autoantibodies. Our study aimed to establish the feasibility of measuring autoantibodies in saliva samples using a novel and highly sensitive method for the detection of autoantibodies. (2) Methods: A total of 48 serum/saliva pairs were collected and tested using a novel particle-based multi-analyte technology (PMAT) system for the presence of a wide range of autoantibodies. (3) Results: A high level of correlation was observed between the results obtained with serum and saliva (Spearman’s rho = 0.725). Study participants clearly preferred saliva over serum sampling as part of the usability assessment. (4) Conclusions: Saliva represents a promising alternative sample matrix for the detection of autoantibodies. The usability study showed a clear preference of saliva over serum as a sample matrix.https://www.mdpi.com/2075-4418/12/8/2026autoantibodiesantinuclear antibodiesautoimmune diseasesaliva |
| spellingShingle | Savino Sciascia Chelsea Bentow Massimo Radin Alice Barinotti Irene Cecchi Silvia Foddai Dario Roccatello Michael Mahler Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients Diagnostics autoantibodies antinuclear antibodies autoimmune disease saliva |
| title | Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients |
| title_full | Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients |
| title_fullStr | Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients |
| title_full_unstemmed | Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients |
| title_short | Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients |
| title_sort | detection of autoantibodies in saliva as new avenue for the diagnosis and management of autoimmune patients |
| topic | autoantibodies antinuclear antibodies autoimmune disease saliva |
| url | https://www.mdpi.com/2075-4418/12/8/2026 |
| work_keys_str_mv | AT savinosciascia detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT chelseabentow detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT massimoradin detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT alicebarinotti detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT irenececchi detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT silviafoddai detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT darioroccatello detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients AT michaelmahler detectionofautoantibodiesinsalivaasnewavenueforthediagnosisandmanagementofautoimmunepatients |